Hemorrhoidal compositions

Claim 2

A topical formulation for treating the symptoms of hemorrhoids comprising a therapeutically effective amount of hydrocortisone in a liquid solution comprising 0.1-0.25 percent by weight of a fungicide-bactericide; 0.075-1.375 percent by weight of a polymeric film-former; 0.5-15 percent by weight of an alcohol; 0.5-25 percent by weight of dimethyl isosorbide; 0.1-0.25 percent by weight of an amphoteric surfactant; 43.0-58.45 percent by weight of hamamelis extract; and a quantity of water sufficient to make a 100% solution.

Claim 3

The topical formulation of claim 1 which comprises a therapeutically effective amount of hydrocortisone in a liquid solution comprising 0.1-0.25 percent by weight of a fungicide-bactericide selected from methyl paraben, propyl paraben, butyl paraben, benzalkonium chloride, cetyl pyridinium chloride, phenyl mercuric chloride, phenol and resorcinol; 0.075-1.375 percent by weight of a polymeric film-former selected from polyvinylpyrrolidone, polymer JR-400, polyvinyl alcohol and sodium carboxymethyl cellulose; 0.5-15 percent by weight of an alcohol selected from propylene glycol, polyethylene glycol-400, isopropyl alcohol and ethyl alcohol; 0.5-25 percent by weight of dimethyl isosorbide; 0.1-0.25 percent by weight of an amphoteric surfactant selected from Miranol C2M-SF Conc., Miranol 2MCA modified, Miranol CM Conc., Miranol MHT; Mirataine CB, Mirataine BB and Mirataine CDMB; 43.0-58.45 percent by weight of hamamelis extract; and a quantity of water to make a 100% solution.

Claim 4

The formulation of claim 2 wherein the hydrocortisone is present in an amount between 0.001 and 0.50 percent by weight.

Claim 5

The formulation of claim 2 wherein the fungicide-bactericide is methyl paraben.

Claim 6

The formulation of claim 2 wherein the polymeric film-former is polyvinylpyrrolidone.

Claim 7

The formulation of claim 2 wherein the alcohol is propylene glycol.

Claim 8

The formulation of claim 2 wherein the amphoteric surfactant is Miranol C2M-SF Conc.

Claim 9

The topical formulation of claim 1 which comprises 0.50 percent by weight of hydrocortisone in a liquid solution comprising 0.25 percent by weight of a fungicide-bactericide selected from methyl paraben, propyl paraben, butyl paraben, benzalkonium chloride, cetyl pyridinium chloride, phenyl mercuric chloride, phenol and resorcinol; 1.0 percent by weight of a polymeric film-former selected from polyvinylpyrrolidone, polymer JR-400, polyvinyl alcohol and sodium carboxymethyl cellulose; 15.0 percent by weight of an alcohol selected from prolylene glycol, polyethylene glycol-400, isopropyl alcohol and ethyl alcohol; 15.0 percent by weight of dimethyl isosorbide; 0.25 percent by weight of an amphoteric surfactant selected from Miranol C2M-SF Conc., Miranol 2MCA modified, Miranol CM Conc., Miranol MHT, Mirataine CB, Mirataine BB and Mirataine CDMB; 50.0 percent by weight of hamamelis extract; and a quantity of water to make a 100% solution.

Claim 10

The topical formulation of claim 8 wherein the formulation contains 0.50 percent by weight of hydrocortisone in a liquid solution comprising 0.25 percent by weight of methyl paraben; 1.0 percent by weight of polyvinylpyrrolidone; 15.0 percent by weight of propylene glycol; 15.0 percent by weight of dimethyl isosorbide; 0.25 percent by weight of Miranol C2M-SF Conc., 50.0 percent by weight of hamamelis extract and 18.0 percent by weight of water.

Claim 11

The topical formulation of claims 1 or 8 wherein the solution is absorbed on a nonwoven cloth material.

Claim 12

A method of treating the symptoms of hemorrhoids which comprises applying to the affected area a topical formulation of claim 1 comprising a therapeutically effective amount of hydrocortisone in a liquid solution consisting of 0.1-0.25 percent by weight of a fungicide-bactericide; 0.075-1.375 percent by weight of a polymeric film-former; 0.5-15 percent by weight of an alcohol; 0.5-25 percent by weight of dimethyl isosorbide; 0.1-0.25 percent by weight of an amphoteric surfactant; 43.0-58.45 percent by weight of hamamelis extract; and a quantity of water sufficient to make a 100% solution.

Claim 13

The method of claim 11 wherein the hydrocortisone is present in an amount between 0.001 and 0.50 percent by weight.

Claim 14

The method of claim 11 wherein the fungicide-bactericide is selected from methyl paraben, propyl paraben, butyl paraben, benzalkonium chloride, cetyl pyridinium chloride, phenyl mercuric chloride, phenol and resorcinol.

Claim 15

The method of claim 11 wherein the fungicide-bactericide is methyl paraben.

Claim 16

The method of claim 11 wherein the polymeric film-former is selected from polyvinylpyrrolidone, polymer JR-400, polyvinyl alcohol and sodium carboxymethyl cellulose.

Claim 17

The method of claim 11 wherein the amphoteric surfactant is selected from Miranol C2M-SF Conc., Miranol 2MCA modified, Miranol CM Conc., Miranol MHT, Mirataine CB, Mirataine BB and Mirataine CDMB.

Claim 18

The method of claim 11 wherein the amphoteric surfactant is Miranol C2M-SF Conc.

Claim 19

The method of claim 11 wherein the polymeric film-former is polyvinylpyrrolidone.

Claim 20

The method of claim 11 wherein the alcohol is selected from propylene glycol, polyethylene glycol-400, ethyl alcohol and isopropyl alcohol.

Claim 21

The method of claim 11 wherein the alcohol is propylene glycol.

Claim 22

The method of claim 11 wherein the formulation contains 0.50 percent by weight of hydrocortisone in a liquid solution comprising 0.25 percent by weight of methyl paraben; 1.0 percent by weight of polyvinylpyrrolidone; 15.0 percent by weight of propylene glycol; 15.0 percent by weight of dimethyl isosorbide; 0.25 percent by weight of Miranol C2M-SF Conc.; 50.0 percent by weight of hamamelis extract and 18.0 percent by weight of water.